Skip to main content

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
SMC Holdings II G.P., LLC OSA ProSomnus, Inc. Common Stock 13D 11.7% 3y
Bain Capital Life Sciences Fund II, L.P. NUVL Nuvalent, Inc. 13D/A 4.2% 3y
Point72 Asset Management, L.P. SMTC Semtech Corp 13G 7.3% 3y
Arturo R. Moreno CCO Clear Channel Outdoor Holdings, Inc. 13D/A 5.6% 3y
Bulldog Investors, LLP PGZ Principal Real Estate Income Fund 13D/A 5.92% 3y
Chan Wai Ho MEGL Magic Empire Global Ltd 13D/A 34.4% 3y
CHEN Sze Hon Johnson MEGL Magic Empire Global Ltd 13D/A 24% 3y
Sean McNealy ABX Abacus Global Management, Inc. 13D/A 20% 3y
Jay Jackson ABX Abacus Global Management, Inc. 13D/A 20% 3y
Matthew Ganovsky ABX Abacus Global Management, Inc. 13D/A 20% 3y
Kevin Scott Kirby ABX Abacus Global Management, Inc. 13D/A 20% 3y
Novator Capital Sponsor Ltd. BETR Better Home & Finance Holding Co 13D/A 13.6% 3y
Deerfield Management Company, L.P. SILK Silk Road Medical, Inc. Common Stock 13G 0% 3y
STILWELL JOSEPH WHLR Wheeler Real Estate Investment Trust, Inc. 13D/A 83.7% 3y
Ray Prudo, M.D. AKTX Akari Therapeutics Plc 13D/A 21.8% 3y
Louis A. DeNaples FNCB FNCB Bancorp Inc. Common Stock 13D/A 10.74% 3y
Samsara BioCapital, L.P. SYRS Syros Pharmaceuticals, Inc. Common Stock 13D 7.5% 3y